Market Overview

Top 4 NYSE Stocks In The Drug Delivery Industry With The Highest Revenue

Share:
Related HSP
3 Biotechs Atlantic Equities Loves And 1 It's Avoiding
Pfizer Upgraded At Cowen On 'Compelling' Valuation, Innovation
Related VRX
Senator Calls Out Bill Ackman, Questions His Senate Hearing Comments On Drug Pricing
Valeant's 10k Finally Released
Valeant Default? Let The Numbers Speak For Themselves - Part II (Seeking Alpha)

Below are the top drug delivery stocks on the NYSE in terms of revenue.

The trailing-twelve-month revenue at Hospira (NYSE: HSP) is $4.02 billion. Hospira had $655.90 million in total cash for the latest quarter.

The trailing-twelve-month revenue at Valeant Pharmaceuticals International (NYSE: VRX) is $2.75 billion. Valeant Pharmaceuticals' operating margin for the same period is 23.99%.

The trailing-twelve-month revenue at Elan Corporation plc (NYSE: ELN) is $1.29 billion. Elan's ROE for the same period is 102.84%.

The trailing-twelve-month revenue at K-V Pharmaceutical Company (NYSE: KV-A) is $23.20 million. K-V Pharmaceutical had $50.70 million in total cash for the latest quarter.

Posted-In: Drug Delivery Industry Highest Revenue NYSETrading Ideas

 

Related Articles (ELN + HSP)

View Comments and Join the Discussion!